Page last updated: 2024-09-02

aporphine and mdl 100907

aporphine has been researched along with mdl 100907 in 1 studies

Compound Research Comparison

Studies
(aporphine)
Trials
(aporphine)
Recent Studies (post-2010)
(aporphine)
Studies
(mdl 100907)
Trials
(mdl 100907)
Recent Studies (post-2010) (mdl 100907)
860471,24165539

Protein Interaction Comparison

ProteinTaxonomyaporphine (IC50)mdl 100907 (IC50)
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0048

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaudhary, S; Harding, WW; Legendre, O; Navarro, HA; Pecic, S1

Other Studies

1 other study(ies) available for aporphine and mdl 100907

ArticleYear
(+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners.
    Bioorganic & medicinal chemistry letters, 2009, May-01, Volume: 19, Issue:9

    Topics: Aporphines; Calcium; Carbon; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Chemical; Molecular Structure; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship

2009